Wellington Management Group LLP bought a new stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm bought 100,255 shares of the technology company's stock, valued at approximately $2,458,000. Wellington Management Group LLP owned approximately 0.50% of Simulations Plus as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of SLP. Janus Henderson Group PLC boosted its holdings in shares of Simulations Plus by 7,753.3% during the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company's stock valued at $15,141,000 after acquiring an additional 535,986 shares in the last quarter. Conestoga Capital Advisors LLC boosted its holdings in shares of Simulations Plus by 17.2% during the 1st quarter. Conestoga Capital Advisors LLC now owns 2,609,388 shares of the technology company's stock valued at $63,982,000 after acquiring an additional 383,126 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of Simulations Plus by 16.7% during the 4th quarter. Ameriprise Financial Inc. now owns 607,902 shares of the technology company's stock valued at $16,954,000 after acquiring an additional 86,868 shares in the last quarter. Stephens Inc. AR boosted its holdings in shares of Simulations Plus by 191.1% during the 1st quarter. Stephens Inc. AR now owns 94,439 shares of the technology company's stock valued at $2,316,000 after acquiring an additional 61,992 shares in the last quarter. Finally, North Star Investment Management Corp. acquired a new stake in shares of Simulations Plus during the 1st quarter valued at $1,300,000. Institutional investors and hedge funds own 78.08% of the company's stock.
Simulations Plus Price Performance
Shares of SLP traded down $0.01 during trading hours on Wednesday, hitting $14.38. The stock had a trading volume of 246,495 shares, compared to its average volume of 429,779. The firm has a 50 day simple moving average of $14.72 and a 200-day simple moving average of $23.70. The firm has a market capitalization of $289.47 million, a P/E ratio of -4.57 and a beta of 0.85. Simulations Plus, Inc. has a 1-year low of $12.39 and a 1-year high of $37.67.
Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its earnings results on Monday, July 14th. The technology company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.26 by $0.19. The company had revenue of $20.36 million during the quarter, compared to the consensus estimate of $22.83 million. Simulations Plus had a positive return on equity of 11.62% and a negative net margin of 78.63%.The firm's revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period last year, the business posted $0.27 EPS. Equities analysts predict that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on the company. JMP Securities reaffirmed a "market perform" rating on shares of Simulations Plus in a research report on Wednesday, June 18th. Stephens lowered their price objective on Simulations Plus from $28.00 to $20.00 and set an "overweight" rating for the company in a research report on Tuesday, July 15th. Craig Hallum lowered their price objective on Simulations Plus from $45.00 to $36.00 and set a "buy" rating for the company in a research report on Friday, June 13th. Zacks Research raised Simulations Plus to a "hold" rating in a research report on Tuesday, August 12th. Finally, KeyCorp lowered Simulations Plus from an "overweight" rating to a "sector weight" rating in a research report on Tuesday, July 15th. Four analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $26.50.
Read Our Latest Analysis on SLP
Simulations Plus Company Profile
(
Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
See Also

Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.